Oral medication for severe hair loss from alopecia areata
Treatments studied
Part of Skin clinical trials.
This study tests an oral medication (SYHX1901) for severe alopecia areata, a condition where the immune system attacks hair follicles, causing significant hair loss. If you qualify, you may receive the study drug to see if it helps regrow hair and improve your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old
- You must have a confirmed diagnosis of alopecia areata (autoimmune-related hair loss) with at least half of your scalp hair gone
- Your current hair loss episode must have started less than 10 years ago, and you should not have had any natural hair regrowth in the past 6 months (though if your total hair loss has lasted over 10 years, you may still be considered)
- You cannot have other scalp conditions or other causes of hair loss (like hair transplants or shaved head)
- You must be willing to use effective contraception during the study and for 28 days after
- You must be in generally good health, without serious infections, heart disease, uncontrolled blood pressure, cancer, or other major medical conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if upadacitinib can help young people with severe alopecia areata (a condition causing patchy hair loss) regrow their hair. It may be an option if hair loss has been present for less than 8 years and there has been no recent improvement.
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
This trial tests an oral medication called NXC-736 for people with moderate to severe alopecia areata. It aims to see if the drug is safe and can help regrow hair.
This study tests an experimental oral tablet for severe alopecia areata, a condition that causes patches of hair to fall out. The goal is to see if it can help regrow hair safely. You may be able to join if you have this type of hair loss and meet the health requirements.
This trial tests a new drug called FB102 for people with severe to very severe alopecia areata, a condition that causes at least half of scalp hair to be lost. It aims to see if the drug is safe and can help hair grow back.
This trial tests an experimental oral tablet (VC005) in teenagers with severe alopecia areata, a condition that causes patchy hair loss. The goal is to see if the drug is safe and may help regrow hair.
Hear when a new Severe Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.